Purity figures for peptides are typically method-dependent chromatographic results tied to a specific lot. This article explains how to read them carefully for in-vitro research documentation.
When a Certificate of Analysis lists a purity percentage for a peptide research reference standard, that value usually reflects chromatographic peak-area ratios under a defined HPLC method. It describes what that method detected for that lot. It is not a general marketing grade that applies to every vial of the same product name forever.
Invus Labs does not invent purity percentages. If a lot has no published CoA, purity should be treated as unpublished—not estimated from similar products or previous batches.
Writing the purity value into notebooks exactly as printed—including the method reference when available—keeps experimental records honest and auditable.
Two laboratories using different columns, gradients, or detection settings may report different chromatographic purity for chemically related samples. Even the same lot retested under a revised method can yield a different number. When comparing certificates, note the method references rather than ranking lots solely by the largest percentage printed.
Understanding HPLC basics helps place purity in context. A high main-peak percentage still leaves open questions about identity support (often addressed by mass spectrometry) and about impurities invisible to that detector.
If your internal method uses a different wavelength or column chemistry than the CoA method, treat supplier purity as contextual information, not as a prediction of your chromatogram’s exact peak-area ratio.
Research-use purity reporting does not imply suitability for human or veterinary administration, diagnostic use, or consumer products. It also does not automatically certify that reconstitution solvents, containers, or laboratory handling preserved the solid as received. Storage and SOP compliance remain laboratory responsibilities.
Avoid language that converts a CoA purity figure into therapeutic, fitness, or performance claims. That framing is outside Invus Labs research positioning.
Purity also does not replace concentration determination after reconstitution. Chromatographic purity of the solid and the molarity of your working solution are related but separate documentation tasks.
Record the lot number, the purity figure exactly as published, and the certificate date in your inventory or method file. When repeating work months later, pull the same lot’s CoA rather than recalling a round number from memory.
For catalog materials such as GHK-Cu, KPV, Ipamorelin, or Tesamorelin reference standards, verify purity only from the published certificate that matches the vial in hand.
When a new lot arrives, update method worksheets so historical runs remain associated with the correct certificate. Mixing lots under one purity assumption is a common source of confusion in shared freezers.
Strong supplier practice means publishing lot certificates when available, labeling vials with batch codes, and refusing to quote invented analytical results. Weak practice includes vague “high purity” claims without lot linkage or copying one certificate across unrelated batches.
Ask whether purity claims on a product page are tied to a specific published CoA. If they are not, treat them as non-actionable for receiving QA.
See also how to evaluate a laboratory reference standard and batch documentation guidance for a fuller purchasing checklist.
When summarizing a peptide reference standard for colleagues, cite the CoA lot, the chromatographic purity as printed, and the method name if present. Avoid compressing that into slogans such as “pharma grade” or “highest purity available.” Those phrases erase method dependence and invite non-research interpretations.
Invus Labs product and research pages are written to keep purity talk anchored to published certificates. Laboratories that mirror that discipline—especially when discussing GHK-Cu, KPV, Ipamorelin, or Tesamorelin lots—reduce both scientific and compliance risk.
If a collaborator asks for a purity number before a CoA is published for the lot on hand, the correct answer is that the figure is unavailable, not that a typical or historical value can be substituted. That single habit prevents impure documentation from entering grant reports, papers, and shared methods.
Invus Labs is a European warehouse and logistics company based in Germany. We supply lyophilized laboratory reference standards for in-vitro research use only.
Contact: support@invuslabs.com
Research use only. Not for human or veterinary use. Not a drug, food, supplement, cosmetic, or medical device.